BioLineRx and Hemispherian report GLIX1 brain PK/PD data and dose GLIX1-C101 fourth cohortNov 16Clinical readoutAllarity TherapeuticsBioLineRx, Ltd.Updated
BioLineRx closes $3.75 million offering, adds warrant coverage from existing investorAug 31FinancingBioLineRx, Ltd.